Resistance to activated protein C (APC resistance) is an important and common risk factor
for deep vein thrombosis. The majority of patients with APC resistance carry a mutation on …

Bennet L, Odeberg H (Blekinge Hospital, Karlskrona, Sweden). Resistance to activated
protein C, highly prevalent amongst users of oral contraceptives with venous …

Resistance to activated protein C (APC-R) is at present considered the most frequent
laboratory abnormality in patients with deep vein thrombosis. An increased risk for venous …

Oral contraceptive (OC) use is associated with an increased risk of venous
thromboembolism. Previous data reported higher thrombotic risk in women using third …

The discovery of plasma resistance towards activated protein C, APC resistance, and its
main genetic background, the presence of a single-point mutation in the gene coding for …

APC resistance is often associated with the occurrence of a single point mutation in factor V
(factor V Leiden) at a predominant cleavage site for the natural anticoagulant, activated …

Hereditary activated protein C (APC) resistance is an established risk factor of venous
thromboembolism, mostly associated with the Arg506-Gln mutation of the factor V gene [1]. A …

Activated protein C (APC) resistance is an established risk factor for venous
thromboembolism. In 5% to 10% of patients with venous thromboembolism, the APC …

OBJECTIVE: Inherited resistance to activated protein C, which is caused by a single factor V
gene mutation, is a frequent risk factor for thrombosis. The purpose of this study was to …

Resistance to activated protein C (APC) is often associated with a mutation in factor V (factor
VLeiden). Individuals without factor VLeiden who exhibit a response in functional APC …